Audience PE Sponsors, Deal Teams, CFOs, Lenders
EBITDA Normalization Quality of Earnings Due Diligence PE Advisory
EBITDA normalization removes non-recurring items from reported earnings, but it does not assess whether the revenue and margins that remain are sustainable or accurately presented.
Seller-prepared normalization adjustments are frequently overstated and require independent verification before they can be relied upon in valuation or debt underwriting.
A Quality of Earnings review goes further: it evaluates revenue quality, customer concentration, accounting policy, working capital, and the assumptions behind management's projections.
At 7x to 10x EBITDA multiples, a $500,000 overstatement in adjusted EBITDA translates directly into $3.5 to $5 million in purchase price exposure.
Every middle market PE transaction arrives with a seller-prepared adjusted EBITDA bridge. The logic is familiar: remove the owner's personal expenses, add back a one-time legal charge, normalize for a non-recurring contract, and present the result as the business's true run-rate earnings. This process is necessary. The problem is that deal teams too often treat it as sufficient.
EBITDA normalization answers one question: what should be removed from reported earnings? It does not evaluate whether the revenue underlying those earnings is concentrated in one or two customers with expiring contracts, whether the company's revenue recognition policies are conservative or aggressive, or whether growing the business will require working capital that compresses free cash flow well below what the EBITDA multiple implies. Those questions require a Quality of Earnings review, and when sponsors skip that step, they are underwriting against a number they have not fully tested.
Seller adjustments, including excess owner compensation, one-time costs, and pro forma revenue from contracts under negotiation, are almost always presented optimistically. Independent QofE work routinely finds that a meaningful share of seller-presented add-backs are either partially supportable or unsupported when subjected to documentary review.
The Valuation Math At an 8x purchase price multiple, a $750,000 reduction in independently supportable EBITDA represents $6 million in overpayment. That gap does not close through post-close operational improvement, as it is locked into the deal structure at signing.
Beyond the adjustments themselves, normalization leaves the most consequential risks unexamined. Revenue concentration, contract renewal risk, aggressive cost capitalization, and working capital dynamics that imply a cash-consumptive business at growth, none of these appear in a normalization bridge. They appear in a QofE review, and they routinely change how a sponsor structures a deal, prices leverage, or sizes a working capital peg.
A Quality of Earnings engagement independently verifies the normalization adjustments, then goes further: it disaggregates revenue by customer and contract to assess concentration and renewal risk, evaluates whether accounting policies are consistent with applicable standards, calculates a normalized working capital requirement, and tests management's projections against historical performance. The result is an independently supported EBITDA figure that a deal team, and its lenders, can underwrite against with confidence.
The cost of a QofE review is small relative to the exposure it addresses. The transactions most likely to underperform are not those in which due diligence surfaced a problem. They are the ones in which the sponsor relied on normalized EBITDA and discovered the gap only after close.
EBITDA normalization is a necessary step in PE deal analysis, but it is not a substitute for a Quality of Earnings review. Normalization removes non-recurring items; it does not assess the quality or sustainability of what remains. In middle market transactions priced at 7x to 10x EBITDA, the difference between seller-adjusted and independently supported earnings has direct and material consequences for purchase price, leverage, and post-close performance. A QofE engagement provides the independent verification and broader analytical coverage that normalization alone cannot.
Related Article For a deeper look at how QofE analysis supports purchase price negotiations and debt underwriting, see: Quality of Earnings and EBITDA Analysis: A Guide for PE-Backed Companies and Their Advisors.
Independent QofE and EBITDA Analysis for Middle Market Transactions
The McLean Group's Financial Advisory practice provides Quality of Earnings reviews, EBITDA normalization analysis, and financial due diligence support for PE sponsors, strategic buyers, and their lenders across buy-side and sell-side engagements.
